DOCSLIB.ORG

Marginable OTC and Foreign Margin Stocks

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Marginable OTC and Foreign Margin Stocks LIST OF MARGINABLE OTC STOCKS 1 AND LIST OF FOREIGN MARGIN STOCKS 2 AS OF May 12, 1997 The List of Marginable OTC Stocks and the List of Foreign Margin Stocks are published quarterly by the Board of Governors of the Federal Reserve System (the Board). The List of Marginable OTC Stocks is composed of stocks traded in the United States over-the-counter (OTC) that have been determined by the Board to be subject to margin requirements as of May 12, 1997, pursuant to Section 207.6 of Federal Reserve Regulation G, ‘‘Securities Credit by Persons Other Than Banks, Brokers, or Dealers,’’ Section 220.17 of Regulation T, ‘‘Credit by Brokers and Dealers,’’ and Section 221.7 of Regulation U, ‘‘Credit by Banks for the Purpose of Purchasing or Carrying Margin Stocks.’’ It also includes all OTC stocks designated as National Market System (NMS) securities. Additional NMS securities may be added in the interim between Board quarterly publications; these securities are immediately marginable upon designation as NMS securities. The names of these securities are available at the National Association of Securities Dealers, Inc. and at the Securities and Exchange Commission. This List supersedes the previous List of Marginable OTC Stocks published effective February 10, 1997. The List of Foreign Margin Stocks is composed of foreign equity securities that have met the Board’s eligibility criteria, pursuant to Regulation T, Section 220.17. These foreign equity securities are eligible for margin treatment at broker–dealers on the same basis as domestic margin securities. This list supersedes the previous List of Foreign Margin Stocks published effective February 10, 1997. CAUTION: It is unlawful for any person to cause any representation to be made that inclusion of a security on the List of Marginable OTC Stocks or the List of Foreign Margin Stocks indicates that the Board or the Securities and Exchange Commission has in any way approved such security or transaction therein. Also, any reference to the Board in connection with these Lists or any securities thereon in an advertisement or similar communication is unlawful. Any inquiry relating to these Lists or to Regulations G, T, U or X should be addressed to the nearest Federal Reserve Bank. 1 (Prepared for Purposes of Regulations G, T, U and X) 2 (Prepared for Purposes of Regulation T Only) BOARD OF GOVERNORS OF THE FEDERAL RESERVE SYSTEM WASHINGTON, D.C. List of Marginable OTC Stocks 1ST BANCORP (Indiana) ABC BANCORP (Georgia) ACE CASH EXPRESS, INC. $1.00 par common $1.00 par common $.01 par common 1ST BERGEN BANCORP ABC DISPENSING TECHNOLOGIES, INC. ACE*COMM CORPORATION No par common $.01 par common $.01 par common 1ST SOURCE CORPORATION ABC RAIL PRODUCTS CORPORATION ACETO CORPORATION $1.00 par common $.01 par common $.01 par common † Fixed rate cumulative trust preferred securities of 1st Source Capital Trust ABER RESOURCES LTD. ACMAT CORPORATION † Floating rate cumulative trust preferred No par common Class A, no par common securities of 1st Source Capital Trust ABIGAIL ADAMS NATIONAL BANCORP, INC. ACRES GAMING INCORPORATED 1ST UNITED BANCORP (Florida) $.01 par common $.01 par common $.01 par common ABINGTON BANCORP, INC. (Massachusetts) ACRODYNE COMMUNICATIONS, INC. 3-D GEOPHYSICAL, INC. $.10 par common $.01 par common $.01 par common ABIOMED, INC. ACT MANUFACTURING, INC. 3-D SYSTEMS CORPORATION $.01 par common $.01 par common $.001 par common ABLE TELCOM HOLDING CORPORATION ACT NETWORKS, INC. 3COM CORPORATION $.001 par common $.01 par common No par common ABR INFORMATION SERVICES INC. ACTEL CORPORATION 3D LABS INC. LIMITED $.01 par common $.001 par common $.01 par common ABRAMS INDUSTRIES, INC. ACTION PERFORMANCE COMPANIES, INC. 3DO COMPANY, THE $1.00 par common $.01 par common $.01 par common ABRAXAS PETROLEUM CORPORATION ACTIVE APPAREL GROUP, INC. 3DX TECHNOLOGIES, INC. $.01 par common $.002 par common $.01 par common ABT BUILDING PRODUCTS CORPORATION ACTIVE VOICE CORPORATION 4 KIDS ENTERTAINMENT, INC. $.01 par common No par common $.01 par common ACACIA RESEARCH CORPORATION ACTIVISION, INC. 4FRONT SOFTWARE INTERNATIONAL, INC. No par common $.0001 par common No par common ACC CONSUMER FINANCE CORPORATION ACTRADE INTERNATIONAL, LTD. 4HEALTH, INC. $.001 par common $.001 par common $.01 par common Warrants (expire 01-15-98) ACC CORPORATION ACXIOM CORPORATION $.015 par common $.10 par common 7TH LEVEL, INC. $.01 par common ACCEL INTERNATIONAL CORPORATION ADAC LABORATORIES $.10 par common No par common A B ELECTROLUX Class B, American Depositary Receipts †ACCELGRAPHICS, INC. ADAGE, INC. $.001 par common $.60 par common A.D.A.M. SOFTWARE, INC. $.01 par common ACCELR8 TECHNOLOGY CORPORATION ADAPTEC, INC. No par common A.S.V., INC. $.001 par common $.01 par common ACCENT COLOR SCIENCES, INC. ADAPTIVE SOLUTIONS, INC. No par common AAON, INC. No par common $.001 par common ACCENT SOFTWARE INTERNATIONAL ADC TELECOMMUNICATIONS, INC. Ordinary Shares par NIS .01 AARON RENTS, INC. $.20 par common $1.00 par common ACCESS ANYTIME BANCORP, INC. $.50 par common $.01 par common ADCO TECHNOLOGIES, INC. $.01 par common AASCHE TRANSPORTATION SERVICES, INC. ACCESS BEYOND, INC. $.0001 par common $.01 par common ADE CORPORATION Warrants (expire 02-09-2000) $.01 par common ACCESS HEALTH, INC. †AASTROM BIOSCIENCES, INC. $.001 par common ADECCO S.A. No par common American Depositary Receipts ACCLAIM ENTERTAINMENT, INC. AAVID THERMAL TECHNOLOGIES, INC. $.02 par common ADELPHIA COMMUNICATIONS CORPORATION $.01 par common Class A, $.01 par common ACCOM, INC. ABACAN RESOURCE CORPORATION $.001 par common ADEPT TECHNOLOGY, INC. No par common No par common ACCUGRAPH CORPORATION ABACUS DIRECT CORPORATION Class A, No par common ADFLEX SOLUTIONS, INC. $.001 par common $.01 par common ACCUMED INTERNATIONAL, INC. ABAXIS, INC. No par common ADIA S.A. No par common Warrants (expire 10-14-97) $.25 par common *Addition to List under Board criteria —1— †Addition to List under NMS designation ADOBE SYSTEMS INCORPORATED AETRIUM INCORPORATED ALDILA, INC. No par common $.001 par common $.01 par common ADTRAN, INC. AFC CABLE SYSTEMS, INC. ALEXANDER & BALDWIN, INC. $.01 par common $.01 par common No par common ADVANCE PARADIGM, INC. AFFILIATED COMMUNITY BANCORP, INC. ALEXION PHARMACEUTICALS, INC. $.01 par common $.01 par common $.0001 par common ADVANCED AERODYNAMICS & STRUCTURES, AFFINITY TECHNOLOGY GROUP, INC. ALFA CORPORATION INC. $.0001 par common $1.00 par common $.0001 par common Class A, warrants (expire 12-03-2001) AFFINITY TELEPRODUCTIONS, INC. ALGOMA STEEL, INC. Class B, warrants (expire 12-03-2001) $.01 par common No par common AFFYMETRIX, INC. ALGOS PHARMACEUTICAL CORPORATION ADVANCED DEPOSITION TECHNOLOGIES, INC. No par common $.01 par common $.01 par common AFSALA BANCORP, INC. (New York) ALIANT COMMUNICATIONS, INC. ADVANCED DIGITAL INFORMATION $.01 par common $.25 par common CORPORATION No par common AFTERMARKET TECHNOLOGY CORPORATION ALICO, INC. $.01 par common $1.00 par common ADVANCED ENERGY INDUSTRIES, INC. $.001 par common AG ASSOCIATES, INC. ALIGN-RITE INTERNATIONAL, INC. No par common $.01 par common ADVANCED FIBRE COMMUNICATIONS $.01 par common AG-CHEM EQUIPMENT CO., INC. ALKERMES, INC. $.01 par common $.01 par common ADVANCED HEALTH CORPORATION $.01 par common AGOURON PHARMACEUTICALS, INC. ALL AMERICAN COMMUNICATIONS, INC. No par common $.0001 par common ADVANCED LIGHTING TECHNOLOGIES, INC. Class B, non-voting, $.0001 par common $.001 par common AGRI-NUTRITION GROUP LIMITED $.01 par common ALL AMERICAN SEMICONDUCTOR, INC. ADVANCED LOGIC RESEARCH, INC. $.01 par common $.01 par common †AGRIBIOTECH, INC. $.001 par common ALL-COMM MEDIA CORPORATION ADVANCED MARKETING SERVICES, INC. $.01 par common $.001 par common †AHL SERVICES, INC. $.01 par common ALLCITY INSURANCE COMPANY ADVANCED POLYMER SYSTEMS, INC. $1.00 par common $.01 par common AIR CANADA CORPORATION Class A, non-voting par common ALLEGIANT BANCORP, INC. ADVANCED RADIO TELECOM CORPORATION $.01 par common $.001 par common AIR EXPRESS INTERNATIONAL CORPORATION $.01 par common ALLEGRO NEW MEDIA, INC. ADVANCED TECHNOLOGY LABORATORIES, INC. $.001 par common $.01 par common AIR METHODS CORPORATION $.06 par common ALLEN ORGAN COMPANY ADVANCED TECHNOLOGY MATERIALS, INC. Class B, $1.00 par common $.01 par common AIRNET SYSTEMS, INC. $.01 par common ALLERGAN LIGAND RETINOID THERAPEUTICS ADVANCED TISSUE SCIENCES, INC. Units (expire 06-05-97) $.01 par common AIRPORT SYSTEMS INTERNATIONAL, INC. $.01 par common ALLIANCE BANCORP, INC. ADVANTA CORP. $.01 par common Class A, $.01 par common AIRSENSORS, INC. ALLIANCE COMMUNICATIONS CORPORATION Class B, non-voting, $.01 par common $.001 par common Class B, non-voting, no par common Depositary Shares Warrants (expire 03-07-98) AIRWAYS CORPORATION ALLIANCE GAMING CORPORATION ADVANTAGE BANCORP, INC. (Wisconsin) $.01 par common $.10 par common $.01 par common Series B, 15% non-voting senior special stock AJAY SPORTS, INC. ADVENT SOFTWARE, INC. Series C, 10% par cumulative convertible * ALLIANCE IMAGING, INC. $.01 par common preferred $.01 par common AEGIS CONSUMER FUNDING GROUP, THE AKORN, INC. ALLIANCE PHARMACEUTICAL CORP. $.01 par common No par common $.01 par common AEP INDUSTRIES, INC. AKSYS, LTD. ALLIANCE SEMICONDUCTOR CORPORATION $.01 par common $.01 par common $.01 par common AER ENERGY RESOURCES, INC. AKZO NOBEL N.V. ALLIED CAPITAL ADVISERS, INC. No par common American Depositary Receipts $.001 par common AERIAL COMMUNICATIONS, INC. ALABAMA NATIONAL BANCORPORATION ALLIED CAPITAL COMMERCIAL CORPORATION $1.00 par common $1.00 par common $.0001 par common AEROVOX INCORPORATED ALADDIN KNOWLEDGE SYSTEMS LTD. ALLIED CAPITAL CORPORATION $1.00 par common Ordinary Shares, NIS .01 par value $1.00 par common AES CHINA GENERATING CO., LTD. ALBANK FINANCIAL CORPORATION ALLIED CAPITAL CORPORATION II Class A, $.01 par common $.01 par common $1.00 par common AES CORPORATION, THE ALCIDE CORPORATION ALLIED CAPITAL LENDING CORPORATION Warrants expire 2001 $.01 par common $.0001 par common *Addition to List under Board criteria —2— †Addition to List under NMS designation ALLIED HEALTHCARE PRODUCTS, INC. AMCORE FINANCIAL, INC. AMERICAN FEDERAL BANK, FSB $.01 par common $.50 par common (South Carolina) $1.00 par common ALLIED HOLDINGS INC.
Load more

Recommended publications
  • UNITED STATES DISTRICT COURT NORTHERN DISTRICT of INDIANA SOUTH BEND DIVISION in Re FEDEX GROUND PACKAGE SYSTEM, INC., EMPLOYMEN
    USDC IN/ND case 3:05-md-00527-RLM-MGG document 3279 filed 03/22/19 page 1 of 354 UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF INDIANA SOUTH BEND DIVISION ) Case No. 3:05-MD-527 RLM In re FEDEX GROUND PACKAGE ) (MDL 1700) SYSTEM, INC., EMPLOYMENT ) PRACTICES LITIGATION ) ) ) THIS DOCUMENT RELATES TO: ) ) Carlene Craig, et. al. v. FedEx Case No. 3:05-cv-530 RLM ) Ground Package Systems, Inc., ) ) PROPOSED FINAL APPROVAL ORDER This matter came before the Court for hearing on March 11, 2019, to consider final approval of the proposed ERISA Class Action Settlement reached by and between Plaintiffs Leo Rittenhouse, Jeff Bramlage, Lawrence Liable, Kent Whistler, Mike Moore, Keith Berry, Matthew Cook, Heidi Law, Sylvia O’Brien, Neal Bergkamp, and Dominic Lupo1 (collectively, “the Named Plaintiffs”), on behalf of themselves and the Certified Class, and Defendant FedEx Ground Package System, Inc. (“FXG”) (collectively, “the Parties”), the terms of which Settlement are set forth in the Class Action Settlement Agreement (the “Settlement Agreement”) attached as Exhibit A to the Joint Declaration of Co-Lead Counsel in support of Preliminary Approval of the Kansas Class Action 1 Carlene Craig withdrew as a Named Plaintiff on November 29, 2006. See MDL Doc. No. 409. Named Plaintiffs Ronald Perry and Alan Pacheco are not movants for final approval and filed an objection [MDL Doc. Nos. 3251/3261]. USDC IN/ND case 3:05-md-00527-RLM-MGG document 3279 filed 03/22/19 page 2 of 354 Settlement [MDL Doc. No. 3154-1]. Also before the Court is ERISA Plaintiffs’ Unopposed Motion for Attorney’s Fees and for Payment of Service Awards to the Named Plaintiffs, filed with the Court on October 19, 2018 [MDL Doc.
    [Show full text]
  • Corporate Profile MUFG UNION BANK, N.A
    MUFG AMERICAS HOLDINGS CORPORATION Corporate Profile MUFG UNION BANK, N.A. MUFG Union Bank, N.A., is a full-service bank with offices has strong capital reserves, credit ratings, and capital across the United States. We provide a wide spectrum ratios relative to peer banks. MUFG Union Bank is a proud of corporate, commercial, retail banking, and wealth member of the Mitsubishi UFJ Financial Group (NYSE: management solutions to meet the needs of customers. MTU), one of the world’s largest financial organizations The bank also offers an extensive portfolio of value-added with total assets of approximately ¥284.9 trillion (JPY) or solutions for customers, including investment banking, $2.3 trillion (USD),¹ as of June 30, 2015. MUFG Americas personal and corporate trust, capital markets, Holdings Corporation, the financial holding company, global custody, transaction banking, and other services. and MUFG Union Bank, N.A., have corporate headquarters With assets of $113.5 billion as of June 30, 2015, the bank in New York City. Enterprise Summary Retail Banking and Wealth Markets Commercial Banking (cont.) Asian Corporate Banking Retail Banking Project Finance Offices: Branch Banking: branches in Real Estate Industries Atlanta, GA California, Oregon, and Washington Technology Chicago, IL — Banking by Design™ checking Houston, TX — Online Banking & Bill Pay U.S. Corporate Banking Florence, KY — Mobile Text Banking & Commodity Finance Los Angeles, CA Check Deposit Energy Finance New York, NY Consumer Lending: Fixed and adjustable Financial Institutions
    [Show full text]
  • Public: Mitsubishi UFJ Financial Group, Inc. Resolution Plan
    Mitsubishi UFJ Financial Group, Inc. Public: Mitsubishi UFJ Financial Group, Inc. Resolution Plan Section 165(d) Resolution Plan MUFG U.S. Resolution Plan Table of Contents Table of Contents Public: Section 1 Public Section 1 1 Introduction 10 1.1 Overview of Mitsubishi UFJ Financial Group, Inc. 10 1.2 Overview of Mitsubishi UFJ Financial Group, Inc.’s U.S. Presence 12 2 Material Entities 13 2.1 Union Bank, N.A. 13 2.2 The New York Branch of the Bank of Tokyo-Mitsubishi UFJ, Ltd. 13 2.3 Mitsubishi UFJ Securities (USA), Inc. 13 2.4 The Bank of Tokyo-Mitsubishi UFJ, Ltd. and UnionBanCal Corporation Integrated Business Initiative 14 3 Core Business Lines 15 3.1 Union Bank, N.A. Core Business Lines 15 3.2 The New York Branch of the Bank of Tokyo-Mitsubishi UFJ, Ltd. Core Business Lines 16 3.3 Mitsubishi UFJ Securities (USA), Ltd. Core Business Lines 17 4 Summary Information Regarding Assets, Liabilities, Capital, and Major Funding Sources 18 4.1 Balance Sheet 18 4.2 Capital 23 4.3 Sources of Funding and Liquidity 24 5 Description of Derivative and Hedging Activities 26 5.1 Mitsubishi UFJ Financial Group, Inc. 26 5.2 Union Bank, N.A. 26 6 Memberships in Material Payment, Clearing, and Settlement Systems 27 7 Description of Foreign Operations 29 8 Material Supervisory Authorities 30 9 Principal Officers 31 9.1 Mitsubishi UFJ Financial Group, Inc. 31 9.2 Union Bank, N.A. 31 10 Resolution Planning Corporate Governance and Processes 33 10.1 165(d) Plan 33 10.2 IDI Plan 34 11 Material Management Information Systems 35 12 Resolution Strategy Summary 36 12.1 Union Bank, N.A.
    [Show full text]
  • Coordination Des Syndicats CGT
    Coordination des syndicats CGT STRATEGIE DE LA DIRECTION DU GROUPE SANOFI CONSEQUENCES INDUSTRIELLES ET SOCIALES Document d’août 2014 1. Situation économique – Coût du capital p2 2. Evolution des effectifs – Bilan des restructurations majeures p3 3. Stratégie Sanofi 2009-2015 : Désengagement scientifique et industriel en Europe et plus particulièrement en France p4 4. Stratégie de structuration du groupe en entités qui peuvent être cédées, vendues, fermées, échangées. p6 5. Crédit d’impôt – Des aides publiques pour quel usage ? p7 6. Industrie pharmaceutique : des besoins fondamentaux p7 7. Interpellation des élus et du gouvernement p8 1. Situation économique – Coût du capital Première entreprise pharmaceutique française et européenne. Sanofi est issu de la fusion de nombreux laboratoires pharmaceutiques français dont les principaux étaient Roussel Uclaf, Rhône Poulenc, Synthelabo, Sanofi et de l’allemand Hoechst. Sanofi représente 30 à 40% du potentiel national (effectifs, sites, R&D,…) de l’industrie pharmaceutique française dans notre pays. L’avenir du groupe et de ses activités en France conditionne l’avenir de l’industrie pharmaceutique française et constitue un élément incontournable de l’indépendance thérapeutique du pays. Le C.A. de sanofi dans le monde sur 2013 a atteint 33 milliards € et devrait se situer à un niveau légèrement supérieur en 2014. Plusieurs médicaments de référence étant aujourd’hui tombés dans le domaine public, le chiffre d’affaires repart à la hausse. Le résultat net des activités a été de 6,8 milliards € en 2013 et les projections sur 2014 laissent envisager une progression de 5% de celui-ci. La rentabilité est estimée par les économistes parmi les meilleures de l’industrie pharmaceutique dans le monde.
    [Show full text]
  • Mitsubishi UFJ Financial Group
    Mitsubishi UFJ Financial Group Annual Report 2008 Year ended March 31, 2008 Mitsubishi UFJ Financial Group (MUFG) is one of the world's largest and most diversified financial groups with total assets of around ¥1 90 trillion as of March 31, 2008. The group comprises five primary operating companies: The Bank of Tokyo-Mitsubishi UFJ, Ltd., Mitsubishi UFJ Trust and Banking Corporation, Mitsubishi UFJ Securities Co., Ltd., Mitsubishi UFJ NICOS Co., Ltd. and Mitsubishi UFJ Lease & Finance Company Limited. MUFG's services include commercial banking, trust banking, securities, credit cards, consumer finance, asset management, leasing and many more fields of financial services. The group has the largest overseas network of any Japanese bank, comprising offices and subsidiaries, including Union Bank of California, in more than 40 countries. ● This annual report is prepared in accordance with U.S. GAAP. To read a discussion with the president and detailed descriptions of our business strategies and initiatives, please refer to MUFG’s Corporate Review 2008, which was published in August 2008. Contents All figures contained in this report are calculated according to Company Overview 1 U.S. GAAP, unless otherwise noted. Financial Highlights 3 This document contains statements that constitute forward-looking statements within the meaning of the United States Private Securities Annual Report on Form 20-F Litigation Reform Act of 1995. Such forward-looking statements represent targets that management will strive to achieve by implementing MUFG’s business
    [Show full text]
  • Announcement of Executive Appointments and the New Management Team
    April 26, 2019 Sony Financial Holdings, Inc. Announcement of Executive Appointments and the New Management Team Tokyo, April 26, 2019——At a Board of Directors’ meeting held today, Sony Financial Holdings Inc. (“SFH”) resolved candidates for election to the position of Directors and Audit & Supervisory Boad Members as stated below. These executive appointments are consistent with reinforcing the management structure to enhance the sustainable corporate value of the Sony Financial Group (“SFG”). We strengthen governance, centering on the Board of Directors at SFH, the holding company. The new executive appointments include outside directors, members of Sony Corporation’s management team, and people from SFH’s management team as directors of SFH. The presidents of the three main subsidiaries (Sony Life Insurance Co., Ltd., Sony Assurance Inc. and Sony Bank Inc.) are allowing them to dedicate themselves to the management of their businesses. Under the new management team, we aim to promote further growth among SFG’s individual businesses and manifest synergies across SFG. Following approval at the Ordinary Meeting of Shareholders, the election of the new management team is subject to the approval of the Board of Directors and the Audit & Supervisory Board, all of which are to be held on June 21, 2019. 1. Changes in Directors <As of June 21, 2019> (1) Resignation Name Current Position *The Position of President, Representative Director of Sony Tomoo Hagimoto Director Life Insurance Co., Ltd. continues. *The Position of President, Representative Director of Sony Atsuo Niwa Director Assurance Inc. continues. *The Position of President, Representative Director of Sony Yuichiro Sumimoto Director Bank Inc.
    [Show full text]
  • Bank of Tokyo-Mitsubishi UFJ Announces Integrated Business Leaders for BTMU Americas Holdings
    Contact: Daniel Weidman (213) 236-4050 [email protected] Lauren Sambrotto (212) 782-4909 [email protected] Bank of Tokyo-Mitsubishi UFJ Announces Integrated Business Leaders for BTMU Americas Holdings NEW YORK/SAN FRANCISCO, July 15, 2013 – The Bank of Tokyo-Mitsubishi UFJ, Ltd. (BTMU) today established an integrated executive committee for BTMU Americas Holdings with jurisdiction for all BTMU operations in the Americas region, including BTMU Headquarters for the Americas in New York and Union Bank, N.A. in San Francisco. Masashi Oka, Chief Executive Officer for the Americas, BTMU, named the following business leaders responsible for the combined business segments of Headquarters for the Americas and Union Bank. Ranjana Clark, Head of Transaction Banking Kevin Cronin, Head of U.S. Corporate Banking Toshi Motoshita, Head of Asian Corporate Banking Michael Stedman, Head of Commercial Banking & Real Estate Tim Wennes, Head of Retail Banking & Wealth Markets Johannes (Johs) Worsoe, Head of Investment Banking and Markets “Assembling these strong leaders into one combined management team will align our business units and amplify their capabilities across geographies and markets,” said Mr. Oka. “This is a major step forward in BTMU’s commitment to the Americas, including the U.S. It will facilitate more investment in the business, and give our customers a broader service model and solution set.” Mr. Oka also announced that Katsumi Hatao will continue as Deputy CEO for the Americas with BTMU Americas Holdings and assumes the additional responsibilities for all Wholesale Banking businesses. About The Bank of Tokyo–Mitsubishi UFJ, Ltd. and Mitsubishi UFJ Financial Group, Inc.
    [Show full text]
  • College Retirement Equities Fund
    SECURITIES AND EXCHANGE COMMISSION FORM N-Q Quarterly schedule of portfolio holdings of registered management investment company filed on Form N-Q Filing Date: 2010-05-27 | Period of Report: 2010-03-31 SEC Accession No. 0000930413-10-003160 (HTML Version on secdatabase.com) FILER COLLEGE RETIREMENT EQUITIES FUND Mailing Address Business Address 730 THIRD AVE 730 THIRD AVE CIK:777535| IRS No.: 136022042 | State of Incorp.:NY | Fiscal Year End: 1231 NEW YORK NY 10017 NEW YORK NY 10017 Type: N-Q | Act: 40 | File No.: 811-04415 | Film No.: 10861628 2129164905 Copyright © 2012 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number File No. 811-4415 COLLEGE RETIREMENT EQUITIES FUND (Exact name of Registrant as specified in charter) 730 Third Avenue, New York, New York 10017-3206 (Address of principal executive offices) (Zip code) Stewart P. Greene, Esq. c/o TIAA-CREF 730 Third Avenue New York, New York 10017-3206 (Name and address of agent for service) Registrants telephone number, including area code: 212-490-9000 Date of fiscal year end: December 31 Date of reporting period: March 31, 2010 Copyright © 2012 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document Item 1. Schedule of Investments. COLLEGE RETIREMENT EQUITIES FUND - Stock Account COLLEGE RETIREMENT EQUITIES FUND STOCK ACCOUNT SCHEDULE OF INVESTMENTS (unaudited) March 31, 2010 MATURITY VALUE PRINCIPAL ISSUER RATE RATING DATE (000) BONDS - 0.0% CORPORATE BONDS - 0.0% HOLDING AND OTHER INVESTMENT OFFICES - 0.0% $ 100,000,000 j Japan Asia Investment Co Ltd 0.000% 09/26/11 NR $ 535 22,970 Kiwi Income Property Trust 8.950 12/20/14 NR 17 TOTAL HOLDING AND OTHER INVESTMENT OFFICES 552 Copyright © 2012 www.secdatabase.com.
    [Show full text]
  • Troubled Company Prospector
    May 21, 2007 Volume 2, Number 21 Prospector Profiles in this Issue Reference Company Name Number Category Profile Aeroflex Incorporated 07.0735 Low Rating AmeriResource Technologies, Inc. 07.0736 Audit Concerns Avicena Group, Inc. 07.0737 Audit Concerns Cardtronics, Inc. 07.0738 Loss/Deficit Chiquita Brands International, Inc. 07.0739 Low Rating Conversion Services International, Inc. 07.0740 Loss/Deficit Digital Lightwave, Inc. 07.0741 Loss/Deficit Envirokare Tech, Inc. 07.0742 Loss/Deficit HydroMaid International, Inc. 07.0743 Bankruptcy Interact Holdings Group, Inc. 07.0744 Audit Concerns INVESTools, Inc. 07.0745 Loss/Deficit ISCO International, Inc. 07.0746 Loss/Deficit Kronos Incorporated 07.0747 Low Rating Lorus Therapeutics, Inc. 07.0748 Loss/Deficit MPC Corporation 07.0749 Loss/Deficit Patient Safety Technologies, Inc. 07.0750 Audit Concerns Plasticon International, Inc. 07.0751 Bankruptcy Samsonite Corporation 07.0752 Loss/Deficit Seaena, Inc. 07.0753 Loss/Deficit Spansion, Inc. 07.0754 Low Rating The Wornick Company 07.0755 Low Rating theglobe.com, Incorporated 07.0756 Loss/Deficit Worldgate Communications, Inc. 07.0757 Loss/Deficit WorldWater & Power Corporation 07.0758 Loss/Deficit (Click on Reference Number to go directly to Company Profile) Intellectual Property Prospector identifies companies with total assets of any size filing for bankruptcy or reporting other financial difficulty and profiles their ownership of intellectual property. The Prospector features companies that meet strictly defined, predetermined criteria and is designed to support the efforts of firms and individuals interested in identifying opportunities in the specific area of intellectual property, which includes patents, trademarks, trade secrets, and licenses, among others. Information is compiled weekly and the Prospector is distributed by email every Sunday evening to arrive before 9:00AM every Monday.
    [Show full text]
  • Ce Que Sanofi Dit De La Politique Industrielle Française
    Ce que Sanofi dit de la politique industrielle française mediapart.fr/journal/economie/030221/ce-que-sanofi-dit-de-la-politique-industrielle-francaise Martine Orange, Mediapart, 3 février 2021 Les salariés de Sanofi ont beau essayer de chercher des explications, ils ne comprennent pas. Ou plutôt ils ne comprennent que trop bien la conduite du groupe pharmaceutique. Après le revers de sa stratégie dans l’élaboration d’un vaccin contre le Covid-19, repoussé désormais au mieux à la fin de l’année, tout aurait dû pousser la direction de Sanofi à s’interroger sur la pertinence de ses choix, sur la place laissée à la recherche jugée comme essentielle. Mais rien ne s’est passé. Le 28 janvier, la direction de Sanofi Recherche et Développement en France a confirmé à l’occasion d’un comité social d’entreprise (CSE) la suppression de 364 emplois en France, une mesure qui vise particulièrement l’unité de Strasbourg appelée à être transférée en région parisienne. Ce plan s’inscrit dans un programme plus large annoncé en juillet 2020. Le groupe entend supprimer 1 700 emplois en Europe dont un millier en France sur trois ans. « Mais ce n’est qu’une partie du projet Pluton, prévient Jean-Louis Perrin, délégué CGT à Montpellier. Sanofi est en train de se désindustrialiser. Toute la pharmacie de synthèse est appelée à disparaître dans le groupe. Les sites de Sisteron, Elbeuf, Vertolaye, Brindisi (Italie), Francfort (Allemagne), Haverhill (Royaume-Uni), Újpest (Hongrie) sont destinés à sortir du groupe. Au total, cela représente 3 500 emplois. » Centre de distribution de Sanofi à Val-de-Reuil.
    [Show full text]
  • Fusiones 20De 20Labo
    "Cuando los grandes se hacen gigantes" Fusiones de Laboratorios 1 INDICE PRÓLOGO……………………………………………………………………………...…….. 3 INTRODUCCIÓN: FUSIONES Y ADQUISICIONES…………………………………..….. 4 INVESTIGACIÓN Y DESARROLLO………………………………………………………. 5 LA INDUSTRIA FARMACEUTICA………………………………………………………. 16 FUSIÓN SANOFI – AVENTIS…………………………………………………………...… 20 FUSIÓN BAYER – SCHERING……………………………………………………………. 26 FUSIÓN PFIZER – WYETH……………………………………………………………….. 30 FUSIÓN MERCK & CO. – SCHERING PLOUGH…………………………………..……. 31 FUSIÓN ROCHE – GENENTECH………………………………………………………… 34 MERCADOS REGIONALES………………………………………………………….…… 40 LA INDUSTRIA FARMACÉUTICA EN LA ARGENTINA……………………...………. 42 CONCLUSIÓN……………………………………………………………………………… 49 2 PRÓLOGO Es un verdadero privilegio que hayan pensado en mí para prologar este interesante trabajo relacionado con la formación profesional de estos inquietos alumnos de la Carrera de Agentes de Propaganda Médica. Grato además, pues recrea mi participación activa en el mundo de la Industria Farmacéutica, en calidad de Asesor de la Fuerza de Ventas e Investigador Principal durante varias décadas, período que fue enriquecedor para mí y sumó un importante valor agregado a mi bagaje médico y personal. Entiendo que lo sucedido en los avances científicos y tecnológicos durante los últimos cuarenta años, ha constituido un quiebre en la Historia de la Medicina y, por lo tanto, de la Humanidad. Es por ello que veo con beneplácito que la formación de estos entusiastas jóvenes va de la mano con los cambios de planes y esquemas de estudios de los futuros médicos.
    [Show full text]
  • The Life of the Abortion Pill in the United States
    The Life of the Abortion Pill in the United States The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation The Life of the Abortion Pill in the United States (2000 Third Year Paper) Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852153 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA 80 The Life of the Abortion Pill in the United States Julie A. Hogan Eleven years after mifepristone1, the drug that chemically induces abortion and hence coined the abortion pill, was approved for use in France, American women still do not have access to the drug, although women in at least ten other nations do.2 In 1988, Americans thought the Abortion Pill [was] on the Hori- zon.3 In 1993, almost five years later, American women still did not have access to the drug, although many women's hopes were raised by newspaper headlines claiming that the Door May Be Open for [the] Abortion Pill to Be Sold in [the] U.S.4 and newspaper accounts predicting that mifepristone would be available in the United States in 1996.5 In 1996, the headlines reported that the Approval of [the] Abortion Pill by the FDA [was] Likely Soon.6 Yet, mifepristone was still not available in 1999, and newspaper headlines were less optimistic about pre- 1Mifepristone is the generic name for RU-486, the designation given the drug by its French maker, Roussel-Uclaf.
    [Show full text]